The MLL Legal competition law team advises both corporations and public entities on all aspects of competition law. We have a business-minded approach and offer a deep specialisation in this area. Our team members are active in international conferences and seminars. We follow the trends in our clients’ industries closely so that we can anticipate developments and help them to avoid competitive risks in the future.
- The main focus of our competition law practice is representing our clients as lead or local counsels before competition authorities as well as civil courts and arbitral tribunals. Our team members are in frequent contact with the Swiss Competition Commission and its Secretariat
- We also advise clients in the structuring of joint ventures, the drafting of distribution agreements and set-up of distribution networks, on the implications of market dominance and regulated markets and on the requirements of national and international merger control
- We help to establish compliance programs and conduct training sessions specifically tailored for our clients and appropriate to their business model, organisation and to their market
“MLL’s competition practice consists of leading practitioners which are located both in Zurich and Geneva. MLL has unique expertise at the intersection of IP and competition law, especially in pharmaceutical antitrust law”
The Legal 500 Country Comparative Guides 2022, October 2022
dRSK, März 2022
- Manuel Kreis
The Law Reviews, Edition 1, 9 November 2021
Michael Reinle, Karin Oberlin and Renato Bucher win Client Choice Awards 2022
MLL Legal ranked in Leaders League Switzerland 2023
Renato Bucher and Hubert Orso Gilliéron listed in Who’s Who Legal Competition
MLL Legal ranked in Who’s Who Legal Switzerland 2022
James Reardon, speaker at the Fit 4 Compliance conference in Zurich, 18 August 2022
Legal Framework for the Use of Psychedelics in Switzerland
Just in time for summer, the miniseries «How to Change Your Mind» will be launched in July on the Netflix streaming platform. In this documentary series, author Michael Pollan and Co. analyse the history and applications of psychedelic substances such as LSD, psilocybin, MDMA and mescaline. According to experts, research with psychedelics (also known as hallucinogens) or related substances will increase worldwide in the coming years. The market launch of drugs containing MDMA for post-traumatic stress disorder (PTSD) or psilocybin for the treatment of depression is expected in the next five to ten years. The legal framework regarding the use of psychedelics in patients is very pragmatic in Switzerland and unique internationally. Switzerland is a leader in the research and use of psychedelics in psychiatry and is considered an innovation driver in this field. Nevertheless, the regulatory hurdles for researchers and patients are still extremely high. In this article we elaborate on the requirements under which psychedelics may be used in Switzerland today.
The proof of damages in case of a premature termination of a distribution agreement: new guidelines by the Swiss Supreme Court
On 3 January 2018, the Swiss Supreme Court rendered a new judgment related to the termination of an exclusive distribution agreement (judgment 4A_27/2018). The decision primarily deals with the proof of damages in connection with a premature termination of a distribution relationship. Moreover, it discusses the proof of the net annual earnings in connection with a claim for goodwill compensation in terms of article 418u of the Swiss Code of Obligations (“CO”). The new decision is of considerable interest, in particular since decisions of the Swiss Supreme Court in distribution related matters are quite rare.More
Switzerland and the United Kingdom sign post-Brexit trade agreement: it is time for businesses to get ready!
On 29 March 2019, at midnight, the United Kingdom (the “UK”) will leave the European Union (the “EU”). If by then the UK and the EU have reached an agreement setting out the arrangements for the UK’s withdrawal from the EU (the “Withdrawal Agreement”), the UK will leave the EU in an “orderly” manner. As a result, there will be a transition period, running at least until the 31st December 2020, during which the UK will remain bound by all EU international agreements, including EU-third-country agreements such as the Swiss-EU bilateral agreements.More
Eyes in the Sky II – Update on Drone Regulation
The Swiss drone ecosystem is flourishing. The growing number of drones however increasingly raises security issues. The regulators in Switzerland as well as in the EU acknowledge the massive potential of the drone economy and are working to build a wider regulatory framework to keep drone operations safe and secure. Therefore, there is quite some movement in the legislative process. This post gives an update on the most recent developments. Until the new drone regulations will take effect, the current Swiss regulation which we have summarized here applies. This post also outlines the key points of U-Space, the landmark project of skyguide (the Swiss air navigation service provider that monitors Swiss airspace). Skyguide has taken the lead in the development of an automated traffic management system for unmanned aircrafts, aiming at setting standards in Switzerland and beyond.More
Algorithmic Price-Fixing Arrangement Justified on Efficiency Grounds
On 7 June 2018, the Luxembourg Competition Authority rendered in a purely domestic case a decision exempting the algorithmic price-fixing arrangement of Webtaxi, a booking platform for taxi services in Luxembourg, on grounds of economic efficiency. In light of the recent case law of the Swiss Federal Supreme Court and the expected concomitant shift of potential defence strategies in cartel cases amongst others to the efficiency test, the decision provides some valuable insights as regards its applicability and functioning, in particular in a platform economy context.More